GlassScriptPhysician profile
Catherine D Smith
NPI 1265171037
$604.28
in general payments reported to CMS, 2019-2025
10 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $116 · 2023: $133 · 2024: $118 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $487.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $150.82 | 2023-2025 | Pomalyst, Opdivo |
| Astellas Pharma US INC | $134.40 | 2025 | Padcev |
| Seagen INC. | $99.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $55.18 | 2024-2025 | |
| Emd Serono, INC. | $41.88 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $33.98 | 2025 | Lynparza |
| Abbvie INC. | $28.03 | 2024 | |
| Genentech USA, INC. | $26.79 | 2025 | Phesgo, Itovebi, Tecentriq Hybreza |
| Incyte Corporation | $17.47 | 2022 | |
| Genmab U.S., INC. | $16.73 | 2024 | Epkinly |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.